Bionano Genomics (BNGO) - Total Stockholders' Equity

This price visualization for Bionano Genomics, Inc. (BNGO), which assists in the basic asset valuation, demonstrates the dynamics of the company developing DNA technologies. The current indicator is 0.03. Patent protection is weakening due to a lack of promotional funds, which is hindering sales. The business relies on a closed genome analysis environment with its own software and chips. However, the risk of product functions being absorbed by industry behemoths poses a serious threat to its survival in the niche.

This indicator is calculated as the daily difference between total assets and liabilities, which allows for the filtering of market noise to capture the actual volume of net assets. The stability of the line on the balance sheet capitalization chart for Bionano Genomics, Inc. (BNGO) provided by GURU.Markets confirms capital preservation, limiting speculative risk for investors in Bionano Genomics, Inc. (BNGO). For a medical innovator in the field of optical genome mapping, such a metric reflects the actual value of the technological base and intellectual property.